Arrow
Arrow
Arrow
Assoc. Prof. MD. Erkan Kayıkçıoğlu
Assoc. Prof. MD. Erkan Kayıkçıoğlu
Assoc. Prof. MD.

Erkan Kayıkçıoğlu

İSÜ Liv Hospital Bahçeşehir
Medical Oncology
Areas of Interests
     
    •  
    • Personalized Medicine
    • İmmunotherapy
    • Breast cancer
    • Lung cancer
    • Colon cancer
    • Prostate cancer
    • Gastric cancer
    • Liver (HCC) Cancer
    • Cervical Cancer
    • Endometrial Cancer
    • Ovarian Cancer
    • Bladder Cancer
    • Kidney Cancer
    • Malignant Melanoma
    • Pancreatic Cancer
    • Testicular Cancer
    • Larynx Cancer
    • Neuroendocrine Tumor
    • Esophageal Cancer
    • Clinical Studies
    • Cancer Genetics
    •  
Resume
Publications
Memberships
Courses Attended
 
Education:
  • Hacettepe University Faculty of Medicine (English)
Specialization Training:
  • Internal Medicine Specialization, Selçuk University Meram Medical Faculty
  • Medical Oncology Specialization, Antalya Training and Research Hospital, Antalya
Institutions works for:
  • Seydişehir State Hospital Internal Medicine Specialist 2010- 2013
  • Antalya Private Life Hospital Internal Medicine Specialist 2013- 2015
  • University of Health Sciences Antalya Training and Research Hospital Medical Oncology Fellow 2015- 2018
  • Recep Tayyip Erdoğan University Faculty of Medicine, Medical Oncology specialist 2018- 2020
  • University of Health Sciences Antalya Training and Research Hospital Medical Oncology specialist 2020-2021
  • Süleyman Demirel University, Faculty of Medicine, Lecturer 2021-2023
  • Beylikdüzü Kolan Hospital 2023
 
  • KAYIKÇIOĞLU ERKAN, Demir Ali (2022). DETERMINATION OF THE FREQUENCY AND ASSOCIATION OF FUNCTIONAL GASTROINTESTINAL DISORDERS IN SELÇUK UNIVERSITY MERAM MEDICAL FACULTY HEALTH WORKERS IN ACCORDANCE WITH THE ROME III CRITERIA. Turkish Journal of Clinics and Laboratory, 13(4), 433-438., Doi: 10.18663/tjcl.788057
  • KAYIKÇIOĞLU ERKAN (2022). Demographic and Clinical Characteristics of Colon Cancer Patients in Isparta Burdur Region. Medical Journal of Suleyman Demirel University, 29(3), 386- 389., Doi: 10.17343/sdutfd.1104209
  • ÜNER SARP, VAİZOĞLU SONGÜL ACAR, ALP SERAP AYNUR, SİMAVLI HÜSEYİN, MAUNSOUR NAİM, EL-HATOU HASSAN, NEPREVİSTA ERVİN, KAYIKÇIOĞLU ERKAN, GÜLER ÇAĞATAY (2007). Evaluation of High School Students' Knowledge and Attitudes About Consumer Rights. BULLETIN OF COMMUNITY MEDICINE, 26(2), 16-21
  • KAYIKÇIOĞLU ERKAN, YÜCEER RAMAZAN OĞUZ (2023). The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes. Ovid Technologies (Wolters Kluwer Health) / MEDICINE, 102(6), Doi: 10.1097/MD.0000000000032882
  • KAYIKÇIOĞLU ERKAN, YÜCEER RAMAZAN OĞUZ, ÇETİN BÜLENT, Yüceer Kamuran, KARAHAN NERMİN (2023). Prognostic value of claudin 18.2 expression in gastric adenocarcinoma. World Journal of Gastrointestinal Oncology, 15(2), 343-351., Doi: 10.4251/wjgo.v15.i2.343
  • KARAÇİN CENGİZ, Oksuzoglu Berna, DEMİRCİ AYŞE, KESKİNKILIÇ MERVE, Baytemü Naziyet Köse, Yılmaz Funda, SELVİ OĞUZHAN, Erdem Dilek, AVŞAR ESİN, PAKSOY NAİL, DEMİR NECLA, SEZGİN GÖKSU SEMA, TÜRKER SEMA, BAYRAM ERTUĞRUL, Çelebi Abdüssamet, Yılmaz Hatice , KUZU ÖMER FARUK, KAHRAMAN SEDA, Gökmen İvo, SAKİN ABDULLAH, ALKAN ALI, NAYIR ERDİNÇ, Uğraklı Muzafer, Acar Ömer, ERTÜRK İSMAİL, Demir Hacer, ASLAN FERİT, SÖNMEZ ÖZLEM, KORKMAZ TANER, CELAYİR ÖZDE MELİSA, KARADAĞ İBRAHİM, KAYIKÇIOĞLU ERKAN, JOKES TEOMAN, Öktem İlker Nihat, EREN TÜLAY, Urul Enes, EYLEMER MOCAN EDA, KALKAN ZİYA, Yıldırım Nilgün, ERGÜN YAKUP, AKAGÜNDÜZ BARAN, KARAKAYA SERDAR, KUT ENGİN, TEKER FATİH, ÇAKAN DEMİREL BURÇİN, KARABOYUN KUBİLAY, Almuradova Elvina, ÜNAL OLÇUN ÜMİT, OYMAN ABDİLKERİM, Işık Deniz, OKUTUR SADİ KEREM (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC Cancer, 23(1), 192, Doi: 10.1186/s12885-023-10609-8
  • KAYIKÇIOĞLU ERKAN, İŞCAN GÖKÇE (2023). A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index. Cureus, Inc., 15(1), Doi: 10.7759/cureus.33808
  • KAYIKÇIOĞLU ERKAN, ÖNDER ARİF HAKAN, Cetin Furkan Bertug, İnal Gulsah (2023). The Efficacy of Pazopanib in Ewing Sarcoma. Chronicles of Precision Medical Researchers, 4(1), 117-118., doi: 10.5281/zenodo.7709543
  • KAYIKÇIOĞLU ERKAN, ÖNDER ARİF HAKAN (2022). The Pan-Immune-Inflammation Value Predicts the Survival of Patients with ER-positive, HER-2-Negative Metastatic Breast Cancer Treated with CDK4/6 inhibitors. Chronicles of Precision Medical Researchers, 3(3), 145- 149., Doi: 10.5281/zenodo.7195780
  • KAYIKÇIOĞLU ERKAN, Aydın Asım Armagan (2022). Prognostic value of clinicopathological characteristic of patients with Malignant Mesothelioma at Mediternean region of Turkey. Cagdas Tip Journal: Journal of Contemporary Medicine, 12(6), 1002-1006., Doi: 10.16899/jcm.1173730
  • KAYIKÇIOĞLU ERKAN, FİNDOS EDA (2022). The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. The Injector, 1(3), 106-114., doi: 10.5281/zenodo.7331456
  • Aydın Asım Armagan, Alparslan Ahmet Şükrü, AYIK HÜLYA, KAYIKÇIOĞLU ERKAN, Ozturk Banu (2018). A challenging palliation via novel therapeutic approach for unusual presenting with gingival metastasis from renal cell carcinoma relapsed eight years after nephrectomy. The European Research Journal, 4(4), 416-420., Doi: 10.18621/eurj.348318
  • ÖNDER ARİF HAKAN, Ozturk Banu, TATLI ALI MURAT, KAYIKÇIOĞLU ERKAN (2018). Acute pancreatitis linked to bevacizumab: A case report. Journal of Oncological Sciences (JOS), 4, 108-110., doi: 10.1016/j.jons.2018.03.004
  • Aydın Asım Armagan, Cetin Furkan Bertug, KAYIKÇIOĞLU ERKAN, Ozturk Banu, Yildiz Mustafa (2017). A unique case of malignant pleural mesothelioma presenting with highly aggressive multiple brain metastases after a long disease-free period. Cumhuriyet Medical Journal, 39(3), 624-628., Doi: 10.7197/223.v39i31705.347463
  • KAYIKÇIOĞLU ERKAN, Aydın Asım Armagan, ÖNDER ARİF HAKAN, SAYINER ALPER, SÜREN DİNÇ, Ozturk Banu (2017). An extremely rare neoplasm, histiocytic sarcoma: A report of two cases with an aggressive clinical course. Journal of Oncological Sciences (JOS), 3, 84-86., doi: 10.1016/j.jons.2017.05.007
  • Aydın Asım Armagan, GÜNDÜZ UMUT RIZA, YALÇINKAYA SONER, KAYIKÇIOĞLU ERKAN, Alparslan Ahmet Şükrü, Yaz Mujgan, Ozturk Banu (2016). A Rare Case of Primary Breast Cancer with Isolated Renal Parenchymal Metastasis Mimicking Primary Renal Cell Carcinoma. Journal of Clinical Case Reports, 6(2), Doi: 10.4172/2165-7920.1000724
  • ATALAY HÜSEYİN, Güney İbrahim, Bağlıcakoğlu Murat, KAYIKÇIOĞLU ERKAN, TONBUL HALİL ZEKİ (2008). Stenotrophomonas maltophilia Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis. Turkish Journal of Nephrology, 17(3), 124-125.
  • ÖZDEMİR SUNA, GLORIOUS HÜSEYİN, ACAR Ali, KAYIKÇIOĞLU ERKAN (2008). Idarubicine Treatment of Acute Myeloblastic Leukemia During Pregnancy: Case Report. Turkiye Klinikleri Journal of Gynecology and Obstetrics, 18, 145-148.
  • ÖZDEMİR SUNA, GLORIOUS HÜSEYİN, ACAR Ali, ÇELİK Çetin, KAYIKÇIOĞLU ERKAN (2008). A Comparison of Maternal and Fetal Outcomes of Pregnancies Complicated by Moderate to Severe Thrombocytopenia Caused by Gestational Thrombocytopenia Preeclampsia / HELLP Syndrome and Immune Thrombocytopenic Purpura. Experimental & Clinical Article, 14(3), 154-158.
  • MYASTENIA GRAVIS AFTER COVID 19 INFECTION AND A CASE OF PLEURAL THYMOMA WITH TREATMENT RESPOND, KAYIKÇIOĞLU ERKAN, AYYILDIZ VEYSEL ATİLLA, EVRIMLER ŞEHNAZ, DÖNGEL İSA, ÇETİN BÜLENT (2021).. 5th NATIONAL IMMUNOTHERAPY AND ONCOLOGY CONGRESS, (Summary paper) B-751- 8986
  • A rare entity: Giant Cell Tumor of Mandibular Bone, KAYIKÇIOĞLU ERKAN, Çetin Bülent (2021).. 5TH NATIONAL IMMUNOTHERAPY AND ONCOLOGY CONGRESS, (Summary paper) B-820-1188
  • Prognostic Significance of Wbp2 Expression in Breast Cancer Patients Receiving C-Erb B2 (Her2) Positive Trastuzumab-Based Treatment in Süleyman Demirel University Faculty of Medicine Medical Oncology Unit, OLGUN NURULLAH VOLKAN, KAYIKÇIOĞLU ERKAN, BOZKURT KEMAL KÜRŞAT, BACAK BURCU, GÜMÜZAY ÖZGE, ÇETİN BÜLENT (2021) 5th NATIONAL IMMUNOTHERAPY AND ONCOLOGY CONGRESS
  • Myasthenia Gravis After Covid 19 Infection and a Case of Pleural Thymoma Responding to Treatment, KAYIKÇIOĞLU ERKAN, AYYILDIZ VEYSEL ATİLLA, EVRIMLER ŞEHNAZ, DÖNGEL İSA, Çetin Bülent (2021).. 5th NATIONAL IMMUNOTHERAPY AND ONCOLOGY CONGRESS, (Summary paper)
  • THE SIGNIFICANCE OF THE PREOPERATIVE FDG PET - CT SUV MAX VALUE ON DISEASE RECURRENCE IN OPERATED NSCLC PATIENTS, KARAMAN ELANUR, KAYIKÇIOĞLU ERKAN (2019).. 3RD NATIONAL IMMUNOTHERAPY AND ONCOLOGY CONGRESS, 3(1), (Summary paper)
  • PSYCHOLOGICAL SYMPTOMS, DEATH ANXIETY AND ANGER IN ELDERLY PATIENS WITH CANCER, KAYIKÇIOĞLU ERKAN, BACIK YAMAN GÖZDE (2023).. 6 Health Sciences and Life Congress,
  • AWARENESS OF CERVICAL CANCER RISK FACTORS AND SCREENING METHODS IN WOMEN RELATIVES OF CANCER PATIENTS, KAYIKÇIOĞLU ERKAN (2023).. INTERNATIONAL EUROASIA
  • COLON CANCER AWARENESS AMONG MALE RELATIVES OF CANCER PATIENTS, KAYIKÇIOĞLU ERKAN (2023).. 10. INTERNATIONAL GEVHER NESİBE MEDICAL SCIENCES CONFERENCE
    THE RELATIONSHIP BETWEEN PERCEIVED STRESS, EMOTION REGULATION, AND ATTACHMENT STYLES IN CANCER PATİENTS, BACIK YAMAN GÖZDE, KAYIKÇIOĞLU ERKAN (2022).. 4. INTERNATIONAL SCIENTIFIC RESEARCH AND INNOVATION CONGRESS
    Albayrak A, Temiz T, Kayıkçıoğlu E. Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey. J Cancer Res Clin Oncol. 2023 Sep;149(12):9621-9627. doi: 10.1007/s00432-023-04890-0. Epub 2023 May 24. PMID: 37222813.
    Sevgioglu ZE, Evrimler S, Iscan G, Kayikcioglu E, Sengul SS, Cetin B. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients. Acta Radiol. 2023 Sep 3:2841851231198345. doi: 10.1177/02841851231198345. Epub ahead of print. PMID: 37661639.
    CURRENT TREATMENT APPROACHES IN BREAST CANCER HORMONE RECEPTOR POSITIVE HER2 NEGATIVE SUBGROUP, KAYIKÇIOĞLU ERKAN (2022).. 1 st INTERNATIONAL – 4 th NATIONAL HEALTH SERVICES CONGRESS
    Hereditary Gynecological Cancers and the Role of Molecular Pathology in Prognosis and Treatment, Section name: (Emerging Agents Targeting DNA Damage Repair Mechanisms) (2022)., KAYIKÇIOĞLU ERKAN, ÇETİN BÜLENT, Turkiye Klinikleri Gynecology Obstetrics - Special Topics Book Identity, Editor :ÜNAL ORHAN, Number of editions: 1, Number of pages 102, ISBN: 978-625-401-840-4, Turkish
    Turkiye Klinikleri Journal of Internal Medical Sciences, Section name:(Mixed Types of MEN Syndromes and Conditions Causing Confusion in MEN1 and MEN2) (2007)., KAYA Ahmet, KAYIKÇIOĞLU ERKAN, TÜRKİYE KLINİKLERİ, Editor:BAHÇECİ Mithat, Number of editions:1 , Number of Pages 48, ISBN:000000000
    Current Treatment Approaches in Oncology 2, Section name: (IMMUNOTHERAPY AGENTS USED IN MEDICAL ONCOLOGY) (2023)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş, Editor: Fatih KÖSE Ali Murat SEDEF, Number of editions: 1, Number of Pages 245, ISBN: 978 -605-258-373-9
    RARE TUMORS, Section name: (TRACHEAL TUMORS) (2022)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş., Editor: Ali Murat SEDEF, Number of editions: 1, Number of Pages 473, ISBN: 978-625-8259-58- 2
    BREAST CANCER, Section name:(SYSTEMIC TREATMENT IN TRIPLE NEGATIVE EARLY STAGE BREAST CANCER) (2019)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş, Editor:Özgür ÖZYILKAN Ali Murat SEDEF Hüseyin Özgür AYTAÇ Ozan Cem GÜLER, Number of editions:1, Page Issue 521, ISBN:978-605-258-550-4
    Geri bildirim gönder
    Yan paneller
    Geçmiş
    Kaydedilenler
    Katkıda bulunu
  • COLON CANCER AWARENESS AMONG MALE RELATIVES OF CANCER PATIENTS, KAYIKÇIOĞLU ERKAN (2023).. 10. INTERNATIONAL GEVHER NESİBE MEDICAL SCIENCES CONFERENCE
  • THE RELATIONSHIP BETWEEN PERCEIVED STRESS, EMOTION REGULATION, AND ATTACHMENT STYLES IN CANCER PATİENTS, BACIK YAMAN GÖZDE, KAYIKÇIOĞLU ERKAN (2022).. 4. INTERNATIONAL SCIENTIFIC RESEARCH AND INNOVATION CONGRESS
  • Albayrak A, Temiz T, Kayıkçıoğlu E. Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey. J Cancer Res Clin Oncol. 2023 Sep;149(12):9621-9627. doi: 10.1007/s00432-023-04890-0. Epub 2023 May 24. PMID: 37222813.
  • Sevgioglu ZE, Evrimler S, Iscan G, Kayikcioglu E, Sengul SS, Cetin B. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients. Acta Radiol. 2023 Sep 3:2841851231198345. doi: 10.1177/02841851231198345. Epub ahead of print. PMID: 37661639.
  • CURRENT TREATMENT APPROACHES IN BREAST CANCER HORMONE RECEPTOR POSITIVE HER2 NEGATIVE SUBGROUP, KAYIKÇIOĞLU ERKAN (2022).. 1 st INTERNATIONAL – 4 th NATIONAL HEALTH SERVICES CONGRESS
  • Hereditary Gynecological Cancers and the Role of Molecular Pathology in Prognosis and Treatment, Section name: (Emerging Agents Targeting DNA Damage Repair Mechanisms) (2022)., KAYIKÇIOĞLU ERKAN, ÇETİN BÜLENT, Turkiye Klinikleri Gynecology Obstetrics - Special Topics Book Identity, Editor :ÜNAL ORHAN, Number of editions: 1, Number of pages 102, ISBN: 978-625-401-840-4, Turkish
  • Turkiye Klinikleri Journal of Internal Medical Sciences, Section name:(Mixed Types of MEN Syndromes and Conditions Causing Confusion in MEN1 and MEN2) (2007)., KAYA Ahmet, KAYIKÇIOĞLU ERKAN, TÜRKİYE KLINİKLERİ, Editor:BAHÇECİ Mithat, Number of editions:1 , Number of Pages 48, ISBN:000000000
  • Current Treatment Approaches in Oncology 2, Section name: (IMMUNOTHERAPY AGENTS USED IN MEDICAL ONCOLOGY) (2023)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş, Editor: Fatih KÖSE Ali Murat SEDEF, Number of editions: 1, Number of Pages 245, ISBN: 978 -605-258-373-9
  • RARE TUMORS, Section name: (TRACHEAL TUMORS) (2022)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş., Editor: Ali Murat SEDEF, Number of editions: 1, Number of Pages 473, ISBN: 978-625-8259-58- 2
  • BREAST CANCER, Section name:(SYSTEMIC TREATMENT IN TRIPLE NEGATIVE EARLY STAGE BREAST CANCER) (2019)., KAYIKÇIOĞLU ERKAN, Akademisyen Kitabevi A.Ş, Editor:Özgür ÖZYILKAN Ali Murat SEDEF Hüseyin Özgür AYTAÇ Ozan Cem GÜLER, Number of editions:1, Page Issue 521, ISBN:978-605-258-550-4
  • European Society For Medical Oncology, Member, 2022.
  • Turkish Medical Oncology Association, Member, 2015
  • Good Clinical Practice- Advanced, Good Clinical Practice- Advanced, Turkey, Certificate, 30.03.2021 (International) 555034
  • Good Clinical Practice, Good Clinical Practice, Türkiye, Certificate, 30.03.2021 (International)
Ask our Experts!
You can contact with our experts for your questions!